Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADAP Adaptimmune Therapeutics plc

提前休市 07-03 13:00:00 EDT

1.02

-0.03

-2.86%

盘后1.02

+0.000.00%

16:55 EDT

最高1.06	最低1.00	成交量74.07万
今开1.06	昨收1.05	日振幅5.71%
总市值2.61亿	流通市值1.74亿	总股本2.56亿
成交额75.61万	换手率0.43%	流通股本1.70亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADAP","market":"US","secType":"STK","nameCN":"Adaptimmune Therapeutics plc","latestPrice":1.02,"timestamp":1720026000000,"preClose":1.05,"halted":0,"volume":740677,"hourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1.02,"latestTime":"16:55 EDT","volume":8342,"amount":8681.661214,"timestamp":1720040152707},"delay":0,"floatShares":170366202,"shares":255561979,"eps":-0.741975,"marketStatus":"提前休市","marketStatusCode":6,"change":-0.03,"latestTime":"07-03 13:00:00 EDT","open":1.06,"high":1.06,"low":1,"amount":756073.3046636,"amplitude":0.057143,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.741975,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1720166400000},"adr":1,"listingDate":1430884800000,"adjPreClose":1.05,"adrRate":6,"preHourTrading":{"tag":"盘前","latestPrice":1.05,"preClose":1.05,"latestTime":"09:02 EDT","volume":591,"amount":616.3652472,"timestamp":1720011758256},"postHourTrading":{"tag":"盘后","latestPrice":1.02,"preClose":1.02,"latestTime":"16:55 EDT","volume":8342,"amount":8681.661214,"timestamp":1720040152707},"volumeRatio":0.757113,"impliedVol":1.0044,"impliedVolPercentile":0.1627},"requestUrl":"/m/hq/s/ADAP","defaultTab":"news","newsList":[{"id":"2448913844","title":"Adaptimmune Therapeutics Plc盘中异动 快速上涨5.24%报1.026美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913844","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913844?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:31","pubTimestamp":1719840672,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时31分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅拉升5.24%。截至发稿，该股报1.026美元/股，成交量2.139万股，换手率0.01%，振幅0.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.05%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213112aef76d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701213112aef76d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2446683623","title":"Adaptimmune Therapeutics Plc盘中异动 早盘急速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446683623","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446683623?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:46","pubTimestamp":1719582380,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时46分，Adaptimmune Therapeutics Plc股票出现异动，股价快速上涨5.02%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Carisma Therapeutics, Inc.较为活跃，换手率分别为344.41%、265.26%、28.00%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Geovax Labs Inc C/Wts 29/09/2025、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为92.60%、45.53%、42.93%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214621aef72997&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214621aef72997&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2446559055","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅上涨5.11%报0.874美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446559055","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446559055?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:37","pubTimestamp":1719499042,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时37分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅拉升5.11%。截至发稿，该股报0.874美元/股，成交量32.721万股，换手率0.13%，振幅4.16%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Kala Bio, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1738.98%、263.29%、246.31%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.，振幅分别为294.39%、127.05%、81.43%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627223722941f1d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627223722941f1d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2444190319","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大跌5.16%报0.958美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444190319","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444190319?lang=zh_cn&edition=full","pubTime":"2024-06-18 01:33","pubTimestamp":1718645595,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日01时33分，Adaptimmune Therapeutics Plc股票出现波动，股价快速下跌5.16%。截至发稿，该股报0.958美元/股，成交量97.1068万股，换手率0.38%，振幅5.94%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Mustang Bio, Inc.、Scinai Immunotherapeutics Ltd、Biocardia Inc C/Wts 06/08/2024涨幅较大，Scinai Immunotherapeutics Ltd、Mustang Bio, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为4922.31%、2719.90%、175.35%，振幅较大的相关个股有Mustang Bio, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scinai Immunotherapeutics Ltd，振幅分别为276.85%、79.35%、53.30%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061801331596814adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061801331596814adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2440111224","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440111224","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440111224?lang=zh_cn&edition=full","pubTime":"2024-06-04 02:55","pubTimestamp":1717440907,"startTime":"0","endTime":"0","summary":"北京时间2024年06月04日02时55分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.31%。截至发稿，该股报1.07美元/股，成交量177.104万股，换手率0.69%，振幅7.08%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Biocardia Inc C/Wts 06/08/2024、Affimed N.V.涨幅较大，Bio-Path Holdings, Inc.、Affimed N.V.、Scorpius Holdings, Inc.较为活跃，换手率分别为3325.48%、184.56%、120.13%，振幅较大的相关个股有Exicure, Inc.、Affimed N.V.、Bio-Path Holdings, Inc.，振幅分别为97.73%、95.17%、86.41%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604025508941ebf7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240604025508941ebf7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2439699258","title":"Adaptimmune Therapeutics Plc股价上涨14.36% 市值涨4238.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439699258","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439699258?lang=zh_cn&edition=full","pubTime":"2024-05-31 21:31","pubTimestamp":1717162318,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日21时31分，Adaptimmune Therapeutics Plc股票出现波动，股价快速拉升14.36%。截至发稿，该股报1.16美元/股，成交量590.474万股，换手率2.31%，振幅0.99%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.41%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213158957fd5b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531213158957fd5b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2439647438","title":"Adaptimmune Therapeutics Plc盘中异动 早盘快速上涨5.94%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439647438","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439647438?lang=zh_cn&edition=full","pubTime":"2024-05-30 21:32","pubTimestamp":1717075965,"startTime":"0","endTime":"0","summary":"北京时间2024年05月30日21时32分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅上涨5.94%。截至发稿，该股报1.07美元/股，成交量7.2297万股，换手率0.03%，振幅1.98%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Kintara Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Gain Therapeutics, Inc.涨幅较大，Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃，换手率分别为32.30%、22.47%、17.08%，振幅较大的相关个股有Prelude Therapeutics Incorporated、Renovorx, Inc.、Entera Bio Ltd.，振幅分别为11.75%、9.76%、9.47%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213245aef28ff9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240530213245aef28ff9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2436980921","title":"Adaptimmune Therapeutics Plc2024财年第一财季实现净利润-48.48百万美元，同比减少4717.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436980921","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436980921?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:16","pubTimestamp":1716135390,"startTime":"0","endTime":"0","summary":"3月31日，Adaptimmune Therapeutics Plc公布财报，公告显示公司2024财年第一财季净利润为-48.48百万美元，同比减少4717.14%；其中营业收入为5.67百万美元，同比减少88.19%，每股基本收益为-0.20美元。从资产负债表来看，Adaptimmune Therapeutics Plc总负债2.34亿美元，其中短期债务5.25百万美元，资产负债比为1.11，流动比率为0.03。机构评级：截至2024年3月31日，当前有7家机构对Adaptimmune Therapeutics Plc目标价做出预测，其中目标均价为2.86美元，其中最低目标价为1.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520001641877abc57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520001641877abc57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2435185376","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435185376","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435185376?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:05","pubTimestamp":1715609122,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时05分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.36%。截至发稿，该股报1.18美元/股，成交量3.9339万股，换手率0.02%，振幅5.87%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Jasper Therapeutics Inc C/Wts 24/09/2026 、Ac Immune Sa涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为50.93%、23.43%、18.89%，振幅较大的相关个股有Dbv Technologies、Tevogen Bio Holdings Inc.、Azitra Inc，振幅分别为36.84%、34.54%、29.77%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132205227a599be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405132205227a599be4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2434869784","title":"Adaptimmune Therapeutics Plc盘中异动 快速下跌5.26%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434869784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434869784?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:21","pubTimestamp":1715358113,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日00时21分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅下跌5.26%。截至发稿，该股报1.08美元/股，成交量31.4007万股，换手率0.12%，振幅10.53%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.05%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100215379270a83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051100215379270a83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2433727158","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433727158","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433727158?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:35","pubTimestamp":1715178944,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日22时35分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅下跌5.00%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 、Cel-Sci Corporation涨幅较大，Enveric Biosciences, Inc.、Allarity Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为230.93%、63.53%、25.91%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Chemomab Therapeutics Ltd，振幅分别为60.74%、43.00%、33.42%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082235447a58c54e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082235447a58c54e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0},{"id":"2433728850","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大跌5.88%报1.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433728850","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433728850?lang=zh_cn&edition=full","pubTime":"2024-05-07 01:26","pubTimestamp":1715016380,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日01时26分，Adaptimmune Therapeutics Plc股票出现波动，股价急速跳水5.88%。截至发稿，该股报1.12美元/股，成交量35.2829万股，换手率0.14%，振幅7.56%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Nrx Pharmaceuticals, Inc.、Nanoviricides, Inc.涨幅较大，Tc Biopharm  Plc、Allarity Therapeutics, Inc.、Lyra Therapeutics, Inc.较为活跃，换手率分别为1226.25%、780.45%、151.86%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Tc Biopharm  Plc、Nrx Pharmaceuticals, Inc.，振幅分别为95.51%、90.41%、68.10%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507012620861eb3c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240507012620861eb3c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2432154635","title":"Adaptimmune Therapeutics Plc盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432154635","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432154635?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:00","pubTimestamp":1714590010,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时00分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅上涨5.04%。截至发稿，该股报1.25美元/股，成交量69.3023万股，换手率0.27%，振幅6.72%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为2.35%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1414.05%、1216.79%、267.07%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502030010861ea959&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502030010861ea959&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2431869349","title":"Adaptimmune Therapeutics Plc盘中异动 快速拉升5.11%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431869349","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431869349?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:36","pubTimestamp":1714397799,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时36分，Adaptimmune Therapeutics Plc股票出现波动，股价急速拉升5.11%。截至发稿，该股报1.13美元/股，成交量4.854万股，换手率0.02%，振幅4.19%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Soleno Therapeutics, Inc.、Zyversa Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为505.71%、24.13%、11.84%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Soleno Therapeutics, Inc.，振幅分别为28.57%、17.43%、14.62%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213640861ea172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429213640861ea172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2429779399","title":"Adaptimmune Therapeutics Plc盘中异动 大幅上涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429779399","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429779399?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:48","pubTimestamp":1713808088,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日01时48分，Adaptimmune Therapeutics Plc股票出现波动，股价快速上涨5.46%。截至发稿，该股报1.030美元/股，成交量34.7582万股，换手率0.14%，振幅7.32%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.89%。其相关个股中，Moolec Science Sa C/Wts 、Nkgen Biotech Inc C/Wts 31/05/2028、Moolec Science Sa涨幅较大，Moolec Science Sa、Phio Pharmaceuticals Corp.、Nkgen Biotech, Inc.较为活跃，换手率分别为196.53%、94.14%、86.47%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Moolec Science Sa、Phio Pharmaceuticals Corp.，振幅分别为252.97%、82.14%、68.75%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042301480987e82908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042301480987e82908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2427866818","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427866818","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427866818?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:39","pubTimestamp":1713199142,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时39分，Adaptimmune Therapeutics Plc股票出现异动，股价急速跳水5.16%。截至发稿，该股报1.10美元/股，成交量63.5798万股，换手率0.25%，振幅9.05%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.23%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600390287e80815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600390287e80815&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptimmune.com","stockEarnings":[{"period":"1week","weight":0.2126},{"period":"1month","weight":-0.0708},{"period":"3month","weight":-0.2391},{"period":"6month","weight":0.2947},{"period":"1year","weight":0.1259},{"period":"ytd","weight":0.3241}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":0.041},{"period":"3month","weight":0.057},{"period":"6month","weight":0.1749},{"period":"1year","weight":0.2371},{"period":"ytd","weight":0.1551}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptimmune Therapeutics Plc成立于2014年12月3日，是一家根据英格兰和威尔士法律注册成立的公众有限公司。该公司是一家临床阶段的生物制药公司，将于2024年过渡到商业阶段的细胞治疗公司。该公司专注于为癌症患者提供新型细胞疗法。公司第一个产品，afamitresgene autoleucel或“afami-cel”是滑膜肉瘤特有的，将是肉瘤产品专营的第一个产品。他们计划于2026年在美国商业推出的Lete-cel将是肉瘤专营权的第二个产品，将同时针对滑膜肉瘤和粘液样圆细胞脂肪肉瘤，显著扩大可治疗的患者群体。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.258042},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016975},{"month":3,"riseRate":0.444444,"avgChangeRate":0.008185},{"month":4,"riseRate":0.666667,"avgChangeRate":0.067805},{"month":5,"riseRate":0.333333,"avgChangeRate":0.165831},{"month":6,"riseRate":0.3,"avgChangeRate":-0.040994},{"month":7,"riseRate":0.4,"avgChangeRate":-0.041518},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.018772},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.012303},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.214893},{"month":11,"riseRate":0.444444,"avgChangeRate":0.062997},{"month":12,"riseRate":0.444444,"avgChangeRate":0.034379}],"exchange":"NASDAQ","name":"Adaptimmune Therapeutics plc","nameEN":"Adaptimmune Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptimmune Therapeutics plc,ADAP,Adaptimmune Therapeutics plc股票,Adaptimmune Therapeutics plc股票老虎,Adaptimmune Therapeutics plc股票老虎国际,Adaptimmune Therapeutics plc行情,Adaptimmune Therapeutics plc股票行情,Adaptimmune Therapeutics plc股价,Adaptimmune Therapeutics plc股市,Adaptimmune Therapeutics plc股票价格,Adaptimmune Therapeutics plc股票交易,Adaptimmune Therapeutics plc股票购买,Adaptimmune Therapeutics plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}